Intrathecal Clinical Trials

1 recruiting

Intrathecal Trials at a Glance

9 actively recruiting trials for intrathecal are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 6 trials, with the heaviest enrollment activity in Cairo, Huizhou, and Kafr ash Shaykh. Lead sponsors running intrathecal studies include Tanta University, Guangzhou Medical University, and Cairo University.

Browse intrathecal trials by phase

Treatments under study

About Intrathecal Clinical Trials

Looking for clinical trials for Intrathecal? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Intrathecal trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Intrathecal clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Not Applicable

Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery

BupivacaineIntrathecal DexmedetomidineKnee Orthopedic Surgery
Cairo University120 enrolled1 locationNCT07522736
Recruiting
Not Applicable

Intrathecal Dexmedetomidine-Fentanyl Combination Versus Fentanyl Alone as Adjuvant to Bupivacaine in Spinal Anesthesia for Above Knee Amputation in Sarcomas of Lower Extremity

DexmedetomidineSarcomasIntrathecal+5 more
National Cancer Institute, Egypt58 enrolled1 locationNCT07276867
Recruiting
Not Applicable

Transversalis Fascia Plane Block Versus Intrathecal Morphine for Postoperative Analgesia in Total Abdominal Hysterectomy

Transversalis Fascia Plane BlockIntrathecal Morphine
Tanta University60 enrolled1 locationNCT07201272
Recruiting
Not Applicable

Transversalis Fascia Plane Block Versus Intrathecal Dexmedetomidine in Patients Undergoing Cesarean Section

Cesarean SectionTransversalis Fascia Plane BlockIntrathecal Dexmedetomidine
Tanta University50 enrolled1 locationNCT07170267
Recruiting
Phase 4

Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases

NSCLCLeptomeningeal MetastasisTyrosine Kinase Inhibitor+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology40 enrolled1 locationNCT07092202
Recruiting
Phase 1Phase 2

Intrathecal PD-1/VEGF Bispecific Antibody Plus Pemetrexed for Leptomeningeal Metastasis

Leptomeningeal MetastasisIntrathecal Drug Delivery
Guangzhou Medical University34 enrolled1 locationNCT06809517
Recruiting
Not Applicable

Combined Intrathecal Dexmedetomidine and Adductor Canal Block for Analgesia After Total Knee Arthroplasty

Intrathecal Dexmedetomidine
Kafrelsheikh University75 enrolled1 locationNCT06837844
Recruiting
Not Applicable

Ultrasound Guided Rectus Sheath Block Versus Intrathecal Morphine for Postoperative Analgesia in Patients Undergoing Open Total Abdominal Hysterectomy

UltrasoundIntrathecal MorphineRectus Sheath Block
Ain Shams University80 enrolled1 locationNCT06837506
Recruiting
Phase 4

Comparative evaluation of isobaric ropivacaine (0.75%) with the adjuvants - clonidine and dexmedetomidine administered intrathecally in adult patients undergoing infra-umbilical surgeries

intrathecal drugs
safdarjung hospital90 enrolled1 locationACTRN12612000581864